Refractory T-Cell Prolymphocytic Leukemia
2 clinical trials · Condition
◉ Watch Refractory T-Cell Prolymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia (NCT04526795) | M.D. Anderson Cancer Center | 2021-04-09 |
Track Refractory T-Cell Prolymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.